Changes in matrix protein biochemistry and the expression of mRNA encoding matrix proteins and metalloproteinases in posterior tibialis tendinopathy

Annals of the Rheumatic Diseases

Volumn 71, Issue 5, 2012, Pages 746-752

  Corps, Anthony N ^a   Robinson, Andrew H N ^a   Harrall, Rebecca L ^a   Avery, Nicholas C ^b   Curry, Valerie A ^a   Hazleman, Brian L ^a   Riley, Graham Peter ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; AGGRECAN; AGGRECANASE 2; ALDIMINE; BIGLYCAN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; DISINTEGRIN; GELATINASE A; GLYCOSAMINOGLYCAN; IMINE; KETOIMINE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 23; MATRIX PROTEIN; MESSENGER RNA; METALLOPROTEINASE; METALLOPROTEINASE 12L; PENTOSIDINE; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSFUNCTIONAL POSTERIOR TIBIALIS TENDON; FEMALE; FLEXOR DIGITORUM LONGUS TENDON; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTERIOR TIBIALIS TENDINOPATHY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENDINITIS; TENDON;

ADULT; AGED; AGED, 80 AND OVER; ARGININE; COLLAGEN; CROSS-LINKING REAGENTS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; GLYCOSAMINOGLYCANS; HUMANS; LYSINE; MALE; METALLOPROTEASES; MIDDLE AGED; RNA, MESSENGER; TENDINOPATHY; TENDON INJURIES; TENDONS; YOUNG ADULT;

EID: 84859503931     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200391     Document Type: Article

References (45)

1. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology (Oxford) 2006;45:508-21.
2. Kohls-Gatzoulis J, Angel JC, Singh D, et al. Tibialis posterior dysfunction: a common and treatable cause of adult acquired flatfoot. BMJ 2004;329:1328-33. (Pubitemid 40754261)
3. Johnson KA, Strom DE. Tibialis posterior tendon dysfunction. Clin Orthop Relat Res 1989;239:196-206. (Pubitemid 19060611)
4. Funk DA, Cass JR, Johnson KA. Acquired adult flat foot secondary to posterior tibialtendon pathology. J Bone Joint Surg Am 1986;68:95-102. (Pubitemid 16184130)
5. Gluck GS, Heckman DS, Parekh SG. Tendon disorders of the foot and ankle, part 3: the posterior tibial tendon. Am J Sports Med 2010;38:2133-44.
6. Wacker JT, Hennessy MS, Saxby TS. Calcaneal osteotomy and transfer of the tendon of flexor digitorum longus for stage-II dysfunction of tibialis posterior. Three- to five-year results. J Bone Joint Surg Br 2002;84:54-8. (Pubitemid 34105625)
7. Lee D. Effects of posterior tibial tendon augmented with biografts and calcaneal osteotomy in stage II adult-acquired flatfoot deformity. Foot Ankle Spec 2009;2:27-31.
8. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford) 2004;43:131-42. (Pubitemid 38219665)
9. Riley G. Tendinopathy-from basic science to treatment. Nat Clin Pract Rheumatol 2008;4:82-9.
10. Bank RA, TeKoppele JM, Oostingh G, et al. Lysylhydroxylation and non-reducible crosslinking of human supraspinatus tendon collagen: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1999;58:35-41. (Pubitemid 29112948)
11. Hansen P, Haraldsson BT, Aagaard P, et al. Lower strength of the human posterior patellar tendon seems unrelated to mature collagen cross-linking and fibril morphology. J Appl Physiol 2010;108:47-52.
12. Couppé C, Hansen P, Kongsgaard M, et al. Mechanical properties and collagen crosslinking of the patellar tendon in old and young men. J Appl Physiol 2009;107:880-6.
13. Thorpe CT, Streeter I, Pinchbeck GL, et al. Aspartic acid racemization and collagen degradation markers reveal an accumulation of damage in tendon collagen that is enhanced with aging. J Biol Chem 2010;285:15674-81.
14. Waggett AD, Ralphs JR, Kwan AP, et al. Characterization of collagens and proteoglycans at the insertion of the human Achilles tendon. Matrix Biol 1998;16:457-70. (Pubitemid 28132525)
15. Benjamin M, Kumai T, Milz S, et al. The skeletal attachment of tendons-tendon "entheses". Comp Biochem Physiol, Part A Mol Integr Physiol 2002;133:931-45.
16. Movin T, Gad A, Reinholt FP, et al. Tendon pathology in long-standing achillodynia. Biopsy findings in 40 patients. Acta Orthop Scand 1997;68:170-5. (Pubitemid 27202080)
17. Corps AN, Robinson AH, Movin T, et al. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) 2006;45:291-4. (Pubitemid 43372843)
18. Riley GP, Curry V, DeGroot J, et al. Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 2002;21:185-95. (Pubitemid 34145243)
19. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum 2006;54:832-42.
20. Moriggl B, Kumai T, Milz S, et al. The structure and histopathology of the "enthesis organ" at the navicular insertion of the tendon of tibialis posterior. J Rheumatol 2003;30:508-17. (Pubitemid 36301943)
21. Petersen W, Hohmann G, Pufe T, et al. Structure of the human tibialis posterior tendon. Arch Orthop Trauma Surg 2004;124:237-42. (Pubitemid 38878342)
22. Mosier SM, Lucas DR, Pomeroy G, et al. Pathology of the posterior tibial tendon in posterior tibial tendon insufficiency. Foot Ankle Int 1998;19:520-4.
23. Gonçalves-Neto J, Witzel SS, Teodoro WR, et al. Changes in collagen matrix composition in human posterior tibial tendon dysfunction. Joint Bone Spine 2002;69:189-94. (Pubitemid 34450362)
24. Fowble VA, Vigorita VJ, Bryk E, et al. Neovascularity in chronic posterior tibial tendon insufficiency. Clin Orthop Relat Res 2006;450:225-30. (Pubitemid 44342139)
25. Riley GP, Goddard MJ, Hazleman BL. Histopathological assessment and pathological significance of matrix degeneration in supraspinatus tendons. Rheumatology (Oxford) 2001;40:229-30. (Pubitemid 32229649)
26. Robins SP. Biochemistry and functional significance of collagen cross-linking. Biochem Soc Trans 2007;35(Pt 5):849-52. (Pubitemid 350206380)
27. de Mos M, van El B, DeGroot J, et al. Achilles tendinosis: changes in biochemical composition and collagen turnover rate. Am J Sports Med 2007;35:1549-56.
28. Riley GP, Harrall RL, Constant CR, et al. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1994;53:367-76. (Pubitemid 24198923)
29. Samiric T, Parkinson J, Ilic MZ, et al. Changes in the composition of the extracellular matrix in patellar tendinopathy. Matrix Biol 2009;28:230-6.
30. Vogel KG, Hernandez DJ. The effects of transforming growth factor-beta and serum on proteoglycan synthesis by tendon fibrocartilage. Eur J Cell Biol 1992;59:304-13. (Pubitemid 23023039)
31. Rees SG, Flannery CR, Little CB, et al. Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J 2000;350 Pt 1:181-8.
32. Samiric T, Ilic MZ, Handley CJ. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 2004;23:127-40. (Pubitemid 38891526)
33. Wang VM, Bell RM, Thakore R, et al. Murine tendon function is adversely affected by aggrecan accumulation due to the knockout of ADAMTS5. J Orthop Res. Published Online First: 16 September 2011. doi:10.1002/jor.21558.
34. Ireland D, Harrall R, Curry V, et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001;20:159-69. (Pubitemid 32564929)
35. Clancy BM, Johnson JD, Lambert AJ, et al. A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. Bone 2003;33:46-63. (Pubitemid 36952687)
36. Rangaraju S, Khoo KK, Feng ZP, et al. Potassium channel modulation by a toxin domain in matrix metalloprotease 23. J Biol Chem 2010;285:9124-36.
37. Kveiborg M, Albrechtsen R, Couchman JR, et al. Cellular roles of ADAM12 in health and disease. Int J Biochem Cell Biol 2008;40:1685-702.
38. Jelinsky SA, Rodeo SA, Li J, et al. Regulation of gene expression in human tendinopathy. BMC Musculoskelet Disord 2011;12:86.
39. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007;26:587-96. (Pubitemid 350180394)
40. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci 1994;732:31-41.
41. Kannus P, Józsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am 1991;73:1507-25.
42. Lo IK, Marchuk LL, Hollinshead R, et al. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons. Am J Sports Med 2004;32:1223-9. (Pubitemid 38970376)
43. Lo IK, Boorman R, Marchuk L, et al. Matrix molecule mRNA levels in the bursa and rotator cuff of patients with full-thickness rotator cuff tears. Arthroscopy 2005;21:645-51. (Pubitemid 40779818)
44. Lakemeier S, Braun J, Efe T, et al. Expression of matrix metalloproteinases 1, 3, and 9 in differing extents of tendon retraction in the torn rotator cuff. Knee Surg Sports Traumatol Arthrosc 2011;19:1760-5.
45. Shindle MK, Chen CC, Robertson C, et al. Full-thickness supraspinatus tears are associated with more synovial inflammation and tissue degeneration than partialthickness tears. J Shoulder Elbow Surg 2011;20:917-27.